In this study, we analyzed plasma CCN1 levels and mRNA sequencing results in 50 healthy controls and 143 patients with type 2 diabetes (74 without DR and 69 with DR) to explore the predictive potential of plasma CCN1 in the diabetic population and the plausible mechanism through which systemic CCN1 affects DR. Here, CCN1 is linked to type 2 diabetes mellitus.